ArticleNano letters2020
An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy.
Jiyoon Bu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this papercites it
ArticleNano letters2020
Jiyoon Bu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.